Deutsche Bank
SANA icon

Deutsche Bank’s Sana Biotechnology SANA Stock Holding History

Deutsche Bank’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
645,087
+53,176
+9% +$171K ﹤0.01% 1838
2026
Q1 		$1.7M Buy
591,911
+29,599
+5% +$117K ﹤0.01% 1854
2025
Q4 		$2.29M Buy
562,312
+18,999
+3% +$85.1K ﹤0.01% 1725
2025
Q3 		$1.93M Buy
543,313
+11,181
+2% +$40.4K ﹤0.01% 1790
2025
Q2 		$1.45M Sell
532,132
-134,260
-20% -$277K ﹤0.01% 1886
2025
Q1 		$1.12M Buy
666,392
+311,692
+88% +$871K ﹤0.01% 2085
2024
Q4 		$578K Sell
354,700
-72,413
-17% -$216K ﹤0.01% 2530
2024
Q3 		$1.78M Sell
427,113
-34,500
-7% -$181K ﹤0.01% 1826
2024
Q2 		$2.52M Buy
461,613
+26,573
+6% +$212K ﹤0.01% 1537
2024
Q1 		$4.35M Buy
435,040
+222,886
+105% +$1.67M ﹤0.01% 1330
2023
Q4 		$866K Sell
212,154
-266,328
-56% -$981K ﹤0.01% 2099
2023
Q3 		$1.85M Buy
478,482
+8,408
+2% +$45.2K ﹤0.01% 1388
2023
Q2 		$2.8M Sell
470,074
-38,966
-8% -$225K ﹤0.01% 1465
2023
Q1 		$1.66M Buy
509,040
+22,212
+5% +$88.7K ﹤0.01% 1785
2022
Q4 		$1.92M Buy
486,828
+7,884
+2% +$38.6K ﹤0.01% 1680
2022
Q3 		$2.87M Buy
478,944
+75,569
+19% +$545K ﹤0.01% 1446
2022
Q2 		$2.59M Buy
403,375
+222,924
+124% +$1.42M ﹤0.01% 1618
2022
Q1 		$1.49M Buy
180,451
+55,789
+45% +$451K ﹤0.01% 2075
2021
Q4 		$1.93M Buy
124,662
+2,973
+2% +$57.3K ﹤0.01% 2019
2021
Q3 		$2.74M Buy
121,689
+104,703
+616% +$2.2M ﹤0.01% 1871
2021
Q2 		$334K Buy
16,986
+1,679
+11% +$38.1K ﹤0.01% 3480
2021
Q1 		$512K Buy
+15,307
New +$498K ﹤0.01% 3084

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Deutsche Bank's SANA Position: Q2 2026 in Review

Deutsche Bank increased its Sana Biotechnology (SANA) stake by 9% in Q2 2026, buying an estimated $171K and bringing the position to 645,087 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Deutsche Bank first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.35M in Q1 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Deutsche Bank held 645,087 shares of Sana Biotechnology worth $2.25M as of Q2 2026.
  • Deutsche Bank bought 53,176 Sana Biotechnology shares in Q2 2026, an estimated $171K.
  • Sana Biotechnology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1838 holding.
  • Deutsche Bank first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Deutsche Bank's Sana Biotechnology position peaked at $4.35M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.